Announcement on the 1st Extraordinary General Meeting in 2025
Filed with SSE · · 3 pages · Chinese
Shanghai Shen Lian Biomedical Corporation on 6ix
Earlier from Shanghai Shen Lian Biomedical
- Announcement on Joint Investment and Related Party Transactions of Wholly-owned Subsidiary
- Announcement on Annual Provision for Asset Impairment in 2024
- Announcement on Resolution of the 1st Meeting of 4th Board of Supervisors
- Announcement on Initially Repurchasing Shares Through Call Auction
- Announcement on Appointment of Accounting Firm
Later from Shanghai Shen Lian Biomedical
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Voluntary Disclosure of Passing GCP Supervision and Inspection for Veterinary Drugs by Ministry of Agriculture and Rural Affairs (MOA)
- 2024 Annual Report
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Attending the Collective Annual Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025 and Convening the Q1 2025 Report Performance Briefing
Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.
Follow Shanghai Shen Lian Biomedical